AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nexus AG

Earnings Release May 23, 2011

305_rns_2011-05-23_4f60c1c5-becf-450a-b9fc-822fef7080d0.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 23 May 2011 08:28

NEXUS AG: Increase of Net Earnings and Sales in the First Quarter 2011

NEXUS AG / Key word(s): Quarter Results

23.05.2011 08:28

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Villingen-Schwenningen, 23 May 2011: Nexus AG, specialized in medical
software, was able to increase sales by 13.4% from KEUR 10,328 in Q1-2010
to KEUR 11,710 in Q1-2011. The sales increase in the Healthcare Software
Division was 14.8% and amounted to KEUR 10,450 following KEUR 9,102 in the
previous year. Sales in the Healthcare Service Division increased by
approx. 2.8% in the first quarter 2011 to KEUR 1,260 (Q1-2010: KEUR 1,226).

The result before taxes improved by 36.0% to KEUR 1,126 (Q1-2010: KEUR 828)
in comparison to the previous year, and the result after taxes increased to
KEUR 668 following KEUR 1,074 in the previous year (+60.8%). The EBITDA
increased by approx. 16.4% to KEUR 2,400 (Q1-2010: KEUR 2,062) during the
reporting period.

The cash flow from current business operations was approx. 10.6% higher
than the previous year at KEUR 4,028 (Q1-2010: KEUR 3,641). Business in
other countries increased by 16.9% to 4,593 in the first quarter 2011
(Q1-2010: 3,930).

NEXUS AG has a healthy balance sheet with approx. EUR 53.6 million equity
capital and - for financing its future growth - sufficient cash reserves.
Cash reserves increased by approx. EUR 3.0 million to EUR 23.7 million
compared to the end of the business year (31 December 2010: EUR 20.7
million).


Information and Explaination of the Issuer to this News:

NEXUS - the eHealth specialist - develops and sells modular software
solutions internationally for healthcare systems in the areas of 'Clinical
Information Systems' (CIS), 'Diagnostic Information Systems' (DIS) and 'IT
Services'. Comprehensive solutions for hospitals and psychiatric
institutions are designed and supported within NEXUS / CIS. The solutions
of NEXUS / DIS cover special ward and specialist areas for radiology,
pathology as well as for gynecology/obstetrics and intensive care medicine.
NEXUS bets on modern, modular software architecture in all product areas,
which enables flexible and step-by-step introduction
of NEXUS systems. More than 450 staff members in the NEXUS Group develop
software solutions for the healthcare sector, with which approximately
108,200 users in 23 countries work.

NEXUS AG
Mr. Simon Holzer

Tel.: +49 (0) 77 21/84 82 0
Fax: +49 (0) 77 21/84 82 888
[email protected]
www.nexus-ag.de

23.05.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: NEXUS AG
Auf der Steig 6
78052 Villingen-Schwenningen
Deutschland
Phone: +49 (0)7721 8482-0
Fax: +49 (0)7721 8482-888
E-mail: [email protected]
Internet: www.nexus-ag.de
ISIN: DE0005220909
WKN: 522090
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.